Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,596 across all filing types
Latest filing 2024-04-08 Share Issue/Capital Cha…
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
关于2023年度以简易程序向特定对象发行限售股份上市流通的提示性公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the lifting of restrictions on certain shares issued to specific investors in 2023, allowing these shares to be freely traded starting April 11, 2024. It details the number of shares, shareholders involved, compliance with regulatory requirements, and the shareholding structure before and after the lifting of restrictions. The document does not contain financial statements or detailed financial performance data but focuses on share issuance, share lock-up expiration, and share circulation. This fits the category of a Share Issue/Capital Change announcement, as it relates to changes in share capital and share circulation status.
2024-04-08 Chinese
关于2021年股票期权激励计划部分股票期权注销完成的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of the cancellation of certain stock options under the company's 2021 stock option incentive plan. It details the procedures followed, the number of stock options cancelled, reasons for cancellation, and the impact on the company. There is no financial statement or comprehensive financial data presented, nor is it a report like an annual or interim report. It is a regulatory announcement about stock option cancellations, which relates to changes in capital structure but is more specific to stock option plan updates rather than new financing or share issuance. The document is not a full capital/financing update but rather a formal announcement of stock option cancellations. Given the specificity and nature of the content, the best fitting category is Regulatory Filings (RNS), as it is a regulatory announcement that does not fit other categories like Capital/Financing Update or Share Issue/Capital Change exactly. The document length is 4423 characters, which is moderate and contains detailed procedural information, supporting this classification.
2024-04-02 Chinese
关于提前归还可转债部分暂时补充流动资金的募集资金的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the early repayment of part of the funds raised through convertible bonds temporarily used to supplement working capital. It discusses the use and repayment of raised funds, referencing previous announcements and the company's board resolutions. The content focuses on capital management and financing activities rather than financial results, management changes, or regulatory certifications. The document length is short (904 characters) and it is a specific update on financing activities related to convertible bonds. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2024-04-01 Chinese
关于提前归还非公开发行部分暂时补充流动资金的募集资金的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the early repayment of part of the funds raised through a non-public issuance used temporarily to supplement working capital. It discusses the board meeting decisions, the amount repaid, and future plans for repayment. There are no financial statements or detailed financial data presented, nor is this a full report or earnings release. The document is a specific update on capital usage and financing activities related to fundraising proceeds. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length and content confirm it is not a mere report publication announcement or regulatory filing fallback.
2024-04-01 Chinese
关于调整2021年股票期权激励计划股票期权数量和行权价格的公告
Board/Management Information Classification · 95% confidence The document is an announcement from a company regarding adjustments to its 2021 stock option incentive plan, specifically changes in the number of stock options and exercise prices. It details board and supervisory meetings, legal opinions, and the rationale for adjustments following the company's equity distribution plan. The content focuses on corporate governance and management decisions related to stock options, not on financial results, earnings, or annual reporting. It is not a full financial report, earnings release, or regulatory filing of financial data. The document is a formal announcement of management decisions about stock option plans, which fits best under Board/Management Information (MANG) as it involves board resolutions and management actions regarding stock incentives.
2024-03-28 Chinese
关于注销2021年股票期权激励计划部分股票期权的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from a company regarding the cancellation of part of its 2021 stock option incentive plan. It details the board and supervisory meetings approving the cancellation, reasons for cancellation (such as employees leaving or performance issues), and the legal and procedural compliance for the cancellation. The document does not contain financial statements or detailed financial performance data but is a regulatory announcement about changes in stock options and related corporate governance matters. It is not a full annual or interim report, nor an earnings release or investor presentation. It is a formal corporate announcement about stock option cancellations, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories like Share Issue/Capital Change (SHA) or Director's Dealing (DIRS).
2024-03-28 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.